Study Summary:
We are currently conducting a phase III study with 5 arms to investigate the efficacy and safety of a new product for the treatment of Diabetes Mellitus Type II.
Qualified Participants Must:
• Be 18 years of age or older
•
Have been diagnosed with type 2 diabetes
•
Be having trouble controlling blood sugars
Qualified Participants May Receive:
Reimbursement for time and travel for participation, medication for treatment provided, office visits, and labs and study related procedures all provided.